Efficacy of Lenvatinib and Sorafenib in the Real-World First-Line Treatment of Advanced-Stage Hepatocellular Carcinoma in a Taiwanese Population.
Teng-Yu LeeSheng-Shun YangHan-Chung LienYen-Chun PengChung-Wang KoTeng-Yu LeePublished in: Journal of clinical medicine (2022)
Lenvatinib, compared to sorafenib, had better ORR and DCR, but similar OS, in Taiwanese patients with advanced-stage HCC. The patients with an objective tumor response had a better OS.
Keyphrases